Data / Form D filings / Gateway Biotechnology, Inc.
Gateway Biotechnology, Inc.: Form D filing
Gateway Biotechnology, Inc., a biotechnology company in Durham, NC, filed a Form D with the SEC in 2025. The latest, on June 5, 2025, reports $633,000 sold of a $2.4 million offering to 4 investors.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 3805 STONEY BROOK DRIVE, Durham, NC, 27705
- Phone
- (607) 229-0349
- Industry
- Biotechnology
- Entity type
- Corporation
- Incorporated in
- North Carolina
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 2071358
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Jun 5, 2025 | New notice | $2,400,000 | $633,000 | $1,767,000 | 4 | May 22, 2025 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Jianxin Bao | Executive Officer | |
| Philip Perez | Director | |
| Richard Chole | Director |
Other biotechnology companies in North Carolina that filed recently
- Toggle Bio $200,000 · Oct 6, 2026
- Swift Cardiovascular, Inc. $810,000 · Sep 24, 2026
- Aclarity Genomics, Inc. $4.6 million · Sep 2, 2026
- Aer Therapeutics, Inc. $3 million · Aug 19, 2026
Every Form D from the week of Jun 2, 2025 · All recent filings in North Carolina · All recent Biotechnology filings
Read from SEC EDGAR. Amount sold is what Gateway Biotechnology, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.